Status:

UNKNOWN

Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis

Lead Sponsor:

Assiut University

Conditions:

Hepatitis C Virus

Eligibility:

All Genders

1-18 years

Brief Summary

observational cross sectional study for children with chronic kidney disease who on regular hemodialysis in assiut univeristy children hospital at dialysis unit, observe prevalence of serological sero...

Detailed Description

Hepatitis C virus (HCV) is a blood-borne pathogen that appears to be endemic in many parts of the world,the highest prevalence of HCV has been found in Egypt (17-26%) The prevalence of HCV infection i...

Eligibility Criteria

Inclusion

  • Age: from 1 year to 18 years
  • CKD children on regular hemodialysis for more than one month duration

Exclusion

  • 1-Age: less than 1 year and more than 18 years 2- CKD children who are not on regular hemodialysis and for less than one month duration

Key Trial Info

Start Date :

October 26 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06104046

Start Date

October 26 2023

End Date

March 31 2025

Last Update

October 27 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.